ArticleGene therapy2013

Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53.

A Reschner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.